Pharma Marketing Network

With all the hoopla about direct-to-consumer (DTC) advertising and diminishing return on physician detailing, physicians are being surveyed more and more about their attitudes...

When using surveys to measure ROI of marketing campaigns -- such as surveys about physician use of eDetailing -- marketers should be wary of comparing one survey's results with another.

Pharmaceutical companies are searching for new, creative solutions to the problem of decreasing sales rep effectiveness. One such solution is to provide physicians with value-added smart tools to allow them instant access to up-to-date prescribing and treatment information.

The shifting pharma landscape makes it all the more important that investors make intelligent choices where to invest their money. The Society of Industry Leaders provides institutional money managers with timely information about the current state of the pharmaceutical market and how it is likely to progress.

Pharmaceutical companies are notorious for their functional and organizational silo structure built around brands. Strategic issues that cross silos -- i.e., cross-boundary issues such as getting marketing and R&D working together, getting a more coordinated global approach to marketing, or getting companies to work better in marketing alliances-are thornier than most because managers don't control all the necessary resources and communication and trust are often weak.

eDetailing proponents, inside pharma companies and outside, use survey data to justify their arguments for greater spending on eDetails. In some cases, however, the numbers seem to show confusing trends and even may suggest that eDetailing may not be all that it's cracked up to be.

You've probably seen ads on TV and in print for several new drugs to treat insomnia. FDA-approved drugs for this condition include AMBIEN (Sanofi-Aventis),...

Leverage Mobile Detailing to Deliver Targeted, Engaging and Valuable Product Information to Physicians

Join us at the leading event for medical device marketing to hear more high-level, informative presentations and gain insight into new regulatory compliance updates, key marketing techniques and ROI models for successful DTC campaigns.

Hear from Rx, OTC, medical device companies and leading industry associations about how to examine and minimize potential liability issues, prepare for the logistical aspects of a recall and evaluate whether to outsource the recall process.